Tau mutations as a novel risk factor for cancer—letter

A.B. Deutschländer; B.F. Boeve; H.J. Rosen; A.L. Boxer; Z.K. Wszolek; D. Brushaber; G. Coppola; B. Dickerson; J. Fong; T. Foroud; L. Forsberg; R. Gavrilova; N. Ghoshal; J. Goldman; J. Graff-Radford; N. Graff-Radford; M. Grossman; H.W. Heuer; G.-Y.R. Hsiung; E.D. Huey; D. Irwin; D. Jones; K. Kantarci; A. Karydas; D. Knopman; J. Kornak; J. Kramer; W. Kremers; W. Kukull; M. Lapid; D. Lucente; I. Mackenzie; S. McGinnis; B. Miller; L. Petrucelli; R. Rademakers; E.M. Ramos; K. Rankin; K. Rascovsky; L. Shaw; J. Syrjanen; J. Taylor; A. Toga; J. Trojanowski; S. Weintraub; B. Wong

doi:10.1158/0008-5472.CAN-18-2313

Back

Tau mutations as a novel risk factor for cancer—letter

Journal article

Open access

Tau mutations as a novel risk factor for cancer—letter

A.B. Deutschländer, B.F. Boeve, H.J. Rosen, A.L. Boxer, Z.K. Wszolek, D. Brushaber, G. Coppola, B. Dickerson, J. Fong, T. Foroud, …

Cancer Research, Vol.78(22), pp.6523-6524

2018

DOI: https://doi.org/10.1158/0008-5472.CAN-18-2313

PMID: 30373809

Abstract

Humans

Mutation

Neoplasms

Risk Factors

chaperone

guanine nucleotide exchange C9orf72

progranulin

tau protein

aneuploidy

apoptosis

brain degeneration

breast cancer

C9orf72 gene

cancer risk

cancer susceptibility

chronic lymphatic leukemia

colon cancer

frontotemporal dementia

gene

gene mutation

GRN gene

human

Letter

malignant neoplasm

MAPT gene

melanoma

ovary cancer

pallidopontonigral degeneration

parkinsonism

phenotype

priority journal

prostate cancer

protein phosphorylation

skin carcinoma

mutation

neoplasm

risk factor

Files and links (2)

url

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056606062&doi=10.1158%2f0008-5472.CAN-18-2313&partnerID=40&md5=123fe3c828490e78191363c4e55b8868View

url

https://doi.org/10.1158/0008-5472.CAN-18-2313View

Published (Version of record) Open

Metrics

1 Record Views

See more details

Details

Title: Tau mutations as a novel risk factor for cancer—letter
Creators: A.B. Deutschländer - Jacksonville College
B.F. Boeve - Mayo Clinic
H.J. Rosen - University of California, San Francisco
A.L. Boxer - University of California, San Francisco
Z.K. Wszolek
D. Brushaber
G. Coppola
B. Dickerson
J. Fong
T. Foroud
L. Forsberg
R. Gavrilova
N. Ghoshal
J. Goldman
J. Graff-Radford
N. Graff-Radford
M. Grossman
H.W. Heuer
G.-Y.R. Hsiung
E.D. Huey
D. Irwin
D. Jones
K. Kantarci
A. Karydas
D. Knopman
J. Kornak
J. Kramer
W. Kremers
W. Kukull
M. Lapid
D. Lucente
I. Mackenzie
S. McGinnis
B. Miller
L. Petrucelli
R. Rademakers
E.M. Ramos
K. Rankin
K. Rascovsky
L. Shaw
J. Syrjanen
J. Taylor
A. Toga
J. Trojanowski
S. Weintraub
B. Wong
Publication Details: Cancer Research, Vol.78(22), pp.6523-6524
Publisher: American Association for Cancer Research Inc.; PHILADELPHIA
Number of pages: 2
Grant note: NIH: U01 AG045390-01A1, U54 NS092089, U24 AG021886, U01 AG016976, P50 NS072187 Medical Research Council: MR/L010933/1, MR/N026004/1 National Institute on Aging: U24AG021886
The LEFFTDS study is supported by the following NIH grants: U01 AG045390-01A1, U54 NS092089, U24 AG021886, U01 AG016976, and P50 NS072187 (to B. Boeve, H. Rosen, A. Boxer, and Z.K. Wszolek).
Comment: Export Date: 27 February 2026; Cited By: 2; CODEN: CNREA
Academic Unit: Level 02 - Executives; Executives; UMMG Department of Neurology
Resource Type: Journal article
PMID: 30373809
Record Identifier: 991032995745902976